The forward momentum of medical progress is manifest, it could be argued, in the $50 billion spent in 2008 on pharmaceutical research and development in the quest to bring new drugs to market. But little scientific or governmental infrastructure exists to ensure that each new treatment is actually an improvement over existing therapies–and to tease out what therapies are best for which patients. [More]
The material in this press release comes from the originating research organization. Content may be edited for style and length. Want more? Sign up for our daily email.